Evidence map›Paper›PMID 20831184›Full record

ArticleBiochemistry2010

Multiple turnovers of the nicotino-enzyme PdxB require α-keto acids as cosubstrates.

Johannes Rudolph, Juhan Kim, Shelley D Copley

Abstract read
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Enhancement of vitamin BMicrobial cell factories · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Relation of theInternational journal of molecular sciences · 2019
    Article
  7. Review
  8. Article
  9. Article
  10. Coupling between d-3-phosphoglycerate dehydrogenase and d-2-hydroxyglutarate dehydrogenase drives bacterial l-serine synthesis.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Article
  12. Article
  13. Inhibitory cross-talk upon introduction of a new metabolic pathway into an existing metabolic network.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Johannes RudolphDepartment of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, CO 80309, USA
Juhan Kim
Shelley D Copley
Cooperative Institute for Research in Environmental Sciences · USInstitut thématique Génétique, génomique et bioinformatique · FRUniversity of Colorado Boulder · US

Funding

Elucidation and Evolutionary Potential of a Latent Pathway for PLP SynthesisR01GM083285 · NIGMS · UNIVERSITY OF COLORADO · PI COPLEY, SHELLEY D. · 2008 to 2016
$2.3M
NIGMS NIH HHS R01 GM083285
6 · The paper itself

Abstract

PdxB catalyzes the second step in the biosynthesis of pyridoxal phosphate by oxidizing 4-phospho-d-erythronate (4PE) to 2-oxo-3-hydroxy-4-phosphobutanoate (OHPB) with concomitant reduction of NAD(+) to NADH. PdxB is a nicotino-enzyme wherein the NAD(H) cofactor remains tightly bound to PdxB. It has been a mystery how PdxB performs multiple turnovers since addition of free NAD(+) does not reoxidize the enzyme-bound NADH following conversion of 4PE to OHPB. We have solved this mystery by demonstrating that a variety of physiologically available α-keto acids serve as oxidants of PdxB to sustain multiple turnovers. In a coupled assay using the next two enzymes of the biosynthetic pathway for pyridoxal phosphate (SerC and PdxA), we have found that α-ketoglutarate, oxaloacetic acid, and pyruvate are equally good substrates for PdxB (k(cat)/K(m) values ~1 × 10(4) M⁻¹s⁻¹). The kinetic parameters for the substrate 4PE include a k(cat) of 1.4 s⁻¹, a K(m) of 2.9 μM, and a k(cat)/K(m) of 6.7 × 10(6) M⁻¹s⁻¹. Additionally, we have characterized the stereochemistry of α-ketoglutarate reduction by showing that d-2-HGA, but not l-2-HGA, is a competitive inhibitor vs 4PE and a noncompetitive inhibitor vs α-ketoglutarate.

Indexed as

Carbohydrate DehydrogenasesEscherichia coli ProteinsKeto AcidsKetoglutaric AcidsKineticsMetabolic Networks and PathwaysOxaloacetatesOxidantsPyridoxal PhosphatePyruvic AcidSubstrate SpecificityCarbohydrate DehydrogenasesEscherichia coli ProteinsKeto AcidsKetoglutaric AcidsOxaloacetatesOxidantspdxB protein, E coliPyridoxal PhosphatePyruvic Acid

Identifiers

PMID20831184
PMCPMC3295541
OpenAlexW2056003961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.